click below
click below
Normal Size Small Size show me how
Immuno 4-30
Question | Answer |
---|---|
upper limb, lateral breast drainage | axillary |
stomach drainage | celiac |
duodenum, jejunum drainage | superior mesenteric |
sigmoid colon drainage | inferior mesenteric |
rectum (lower portion above the pectinate) | internal iliac |
anal canal below pectinate line | superfician inguinal |
testes | para aortic |
scrotum | superficial inguinal |
thigh (superficial) | superficial inguinal |
lateral side of dorsum of foot | popliteal |
NK activity enhanced by what? | IL12, IFN beta, interferon alpha |
when will NK kill | lack of MHC I on target cell nonspecific activation signal on target cell |
opsonize bacteria | IgG |
neutralize viruses | IgG |
activate complement | IgG and IgM |
sensitize mast cells | IgE |
cytotoxic type 2 hypersensitivity | IgG |
immune complex type 3 hypersensitivity | IgG |
hyperacute organ rejection | antibody b cell mediated |
acute and chronic organ rejection | T cell mediated |
C1, C2, C3, C4 | viral neutralization |
C3b, IgG | opsonization |
C3a, C5a | Anaphylaxis |
C5a | neutrophil chemotaxis |
ACE inhibitors are contraindicated with what deficiency? | C1 esterase inhibitor deficiency |
hereditary angioedema | C1 esterase inhibitor deficiency |
C3 deficiency | severe, recurrent pyogenic sinus and respiratory tract infections increased susceptibility to type III hypersensitivity reaction |
increased susceptibility to type 3 hypersenstivitiy reaction | C3 deficiency |
recurrent Neisseria bactermia | C3-C8 deficiencies |
DAF (GPI anchored enzyme) deficiency | complement mediated lysis of RBC PNH |
Inhibits viral protein synthesis by degrading viral mRNA (but not host mRNA) | ribonuclease of interferons |
increased MHC I and II expression and antigen expresentation in all cells | gamma interferon |
activates NK cells to kill virus intected cells | interferons |
inhibit viral protein synthesis | alpha and beta interferons |
CD markers for macrophages | CD14 CD40 |
NK cell CD markers | CD16 (binds Fc of IgG) CD56 |
T cell CD markers | CD3 CD28 |
B cell CD markers | CD19, CD20, CD21 (receptor for EBV) CD40 |
bacteria antigen variation of salmonella | 2 flagellar variants |
borrelia antigen variation | relapsing fever |
neisseria gonorrhoaea variation | pilus protein |
virus variation | influenza |
parasite antigen variation | trypanosomes (programmed rearrangement) |
live attenuated vaccine induces what kind of response? | cellular |
inactivated or killed vaccine -> what kind of response? | humoral |
live attenuated vaccines | Come see small yellow chickens get vaccinated with MMR and polio. small pox, chicken pox, yellow fever mumps, measles, rubella, polio (Sabin) |
inactivated/killed vaccines | cholera, influenza, hepatitis A, polio (salk), rabies |
hypersenstivity pneumonitis (farmer's lung) | type 3 hypersensitivity |
granulomatosis with polangiitis autoAB | c-ANCA |
anti smooth muscle | autoimmune hepatitis |
anti glutamate decarboxylase | type I DM |
anti U1 RNP | mixed connected tissue disorder |
Anti Jo1 | polymyositis, dermatomyositis |
no T cell infections | sepsis CMV, EBV, VZV, chornic infection with respiratory/gi viruses candida, PCP |
no b cell bacterial infections | encapsulated (strep, staph, h. influ, MORAXELLA) |
no B cell viral infections | enteroviral encephalitis poliovirus (live vaccine contraindicated) |
no B cell parasite infection | GI giardiasis (no IgA) |
produce recurrent bacterial infections | no b cell |
produce more fungal and viral infectiosn | no T cell deficiencies |
no complement | neisseria (no Myocbacterium avium complex) |
can be acquired in 20s - 30s, risk of AI disease, lymphoma, sinopulmonary infections | CVID |
hyper IgE | coarse Faces cold staph Abscesses retained primary Teeth increased IgE dermatologic eczema |
disemminated mycobacterial infections and salmonella infection | IL12 receptor deficiency decreased Th1 response |
partial albinism, peripheral neuropathy, recurrent pyogenic infections by staph and strep | chediak higashi syndrome |
defect in lysosomal regulator trafficking gene | chediak higashi syndrome |
alpha interferon | Hep B and Hep C kaposi's sarcoma leukemia malignant melaoma |
oprelvekin (il-11) | thrombocytopeia |
sargramostim (GM CSF) | recovery of bone marrow |
filgrastim (G-CSF) | recovery of bone marrow |
aldesleukin | IL-2 |
aldesleukin use | renal cell carcinoma metastatic melanoma |
omalizumab | IgE additional line of treatment for severe asthma |
rituximab | B cell non Hodgkin's lymphoma |
trastuzumab | HER2 overexpressing breast cancer |
adalimumab | TNF alpha |
adalimumab | Crohn's disease, rheumatoid arthritis psoriatic arthritis |
infliximab | TNF-alpha Crohn's disease rheumatoid arthritis, psrioatic arthritis, ankylosing spodylitis |
digoxin immune Fab | antidoe for digoxin intoxication |
daclizumab | IL-2 prevent acute rejection of renal transplant |